Pathogen-Reduced Platelets for the Prevention of Bleeding in People of Any Age
- 1 April 2018
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 4 (4) , 571-+
Abstract
Clinical Question Are pathogen-reduced platelets as effective as standard platelets for the prevention of bleeding in people of any age requiring platelet transfusions? Bottom Line In people with cancer who have a low platelet count due to their disease or its treatment, pathogen-reduced platelet transfusions increase risk of platelet refractoriness and platelet transfusion requirement (high-quality evidence) but probably do not effect all-cause mortality, risk of clinically significant or severe bleeding, or risk of a serious adverse event (moderate-quality evidence). There was insufficient evidence for people with other diagnoses.Keywords
This publication has 1 reference indexed in Scilit: